良性前列腺增生症：计算其治疗成本 - Suppr

Suppr

超能文献

Benign prostatic hyperplasia: counting the cost of its management.

作者信息

Kirby Roger S, Kirby Mike, Fitzpatrick John M

机构信息

The Prostate Centre, London, UK.

出版信息

BJU Int. 2010 Apr;105(7):901-2. doi: 10.1111/j.1464-410X.2010.09274.x.

DOI:10.1111/j.1464-410X.2010.09274.x

PMID:20356323

Abstract

摘要

相似文献

Benign prostatic hyperplasia: counting the cost of its management.

BJU Int. 2010 Apr;105(7):901-2. doi: 10.1111/j.1464-410X.2010.09274.x.

The management of benign prostatic obstruction: a voice from the Third World.

BJU Int. 2006 Apr;97(4):671-2. doi: 10.1111/j.1464-410X.2006.06062.x.

A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.

J Urol. 2006 Oct;176(4 Pt 1):1500-6. doi: 10.1016/j.juro.2006.06.064.

Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.

Scand J Urol Nephrol. 2002;36(4):286-95. doi: 10.1080/003655902320248263.

A cost comparison of medical management and transurethral needle ablation for treatment of benign prostatic hyperplasia during a 5-year period.

J Urol. 2005 Jun;173(6):2090-3; discussion 2093. doi: 10.1097/01.ju.0000158451.30419.66.

Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.

J Urol. 2007 Mar;177(3):1047-51; discussion 1051. doi: 10.1016/j.juro.2006.10.042.

Benign prostatic hyperplasia: counting the cost of its management.

BJU Int. 2010 Aug;106(4):586. doi: 10.1111/j.1464-410X.2010.09551_2.x.

Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis.

BJU Int. 2004 May;93(7):1118-9. doi: 10.1111/j.1464-410X.2004.4834i.x.

An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.

BJU Int. 2006 May;97(5):1007-16. doi: 10.1111/j.1464-410X.2005.06089.x. Epub 2006 Mar 17.

Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway.

Scand J Urol Nephrol. 2007;41(2):124-31. doi: 10.1080/00365590600911266.

引用本文的文献

Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain.

Int J Clin Pract. 2021 Aug;75(8):e14250. doi: 10.1111/ijcp.14250. Epub 2021 May 29.

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.

Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD012336. doi: 10.1002/14651858.CD012336.pub2.

Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain.

Int J Clin Pract. 2020 Nov;74(11):e13602. doi: 10.1111/ijcp.13602. Epub 2020 Aug 16.

A Prospective Study of Physical Activity, Sedentary Behavior, and Incidence and Progression of Lower Urinary Tract Symptoms.

J Gen Intern Med. 2020 Aug;35(8):2281-2288. doi: 10.1007/s11606-020-05814-1. Epub 2020 Apr 28.

Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.

Cochrane Database Syst Rev. 2019 Dec 3;12(12):CD009629. doi: 10.1002/14651858.CD009629.pub4.

Costs of Managing Benign Prostatic Hyperplasia in the Office and Operating Room.

Curr Urol Rep. 2018 Jul 19;19(9):72. doi: 10.1007/s11934-018-0822-z.

Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia.

BMC Urol. 2017 Sep 12;17(1):83. doi: 10.1186/s12894-017-0275-6.

BMJ Open. 2017 Feb 8;7(2):e013737. doi: 10.1136/bmjopen-2016-013737.

Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey.

Int J Clin Pract. 2016 Oct;70(10):870-880. doi: 10.1111/ijcp.12879.

Cost of illness of medically treated benign prostatic hyperplasia in Hungary.

Int Urol Nephrol. 2015 Aug;47(8):1241-9. doi: 10.1007/s11255-015-1028-7. Epub 2015 Jun 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验